Investigational Site Number : 3000004

Thessaloniki 57010

1 studies enrolling now · 3 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Hidradenitis Suppurativa, Plasma Cell Myeloma Recurrent

Studies at this site

• Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa — Recruiting now
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed